Member Info for rivaldo

Good to see VLE restarting the buybacks as I hoped, buying back shares at 1290p yesterday:

Https://www.investegate.co.uk/volvere-plc--vle-/rns/transaction-in-own-shares/202009300738575654A/

Good news this morning from Altus Strategies - successful results, but more to the point, further exploration drilling to commence in this Q4:

Https://www.londonstockexchange.com/news-article/ALS/increase-in-gold-resource-at-tabakorole-project/14702897

Very important news for EKF just out today:

Htts://www.ekfdiagnostics.com/primestore-mtm-evaluated-by-public-health-england-for-sars-cov-2.html

"PrimeStore® MTM successfully evaluated by Public Health England for SARS-CoV-2 inactivation

The novel viral transport media PrimeStore® MTM (Molecular Transport Medium) has been successfully evaluated for effective SARS-CoV-2 inactivation in a new study published by Public Health England (PHE) [1]. To work safely with live SARS-CoV-2 samples requires the use of high-containment laboratories. However, after inactivation SARS-CoV-2 material can be handled at a lower containment level, allowing more laboratories to undertake testing and thereby increasing COVID-19 testing capacity.

The PHE study [1] evaluated numerous commercially available reagents and laboratory formulations commonly used for viral inactivation protocols by public health agencies and research laboratories globally. All the reagents tested have been used during the current COVID-19 pandemic for sample transportation and subsequent molecular processing. A total of 23 commercial reagents designed for virus inactivation, clinical sample transportation and nucleic acid extraction were assessed by PHE for their ability to inactivate SARS-CoV-2.

The study used TCID50 and blind passage techniques to test for any infectious virus still recoverable from all samples treated with the inactivation reagents. Notably, the study showed that PrimeStore MTM was the only commercially available transport reagent from the many tested from which no residual virus was detectable by either TCID50 or by the passaging of treated purified sample. This demonstrates the efficacy and safety of PrimeStore MTM in inactivating live SARS-CoV-2 samples whilst maintaining the ability to detect the target viral RNA.

In addition to this successful PHE evaluation of its effectiveness at deactivating SARS-CoV-2, PrimeStore MTM is also an FDA cleared and CE-IVD marked sample collection device. It is already well proven, with millions of tubes sold globally for the inactivation and transportation of many high consequence pathogens. Therefore, this patented transport media, manufactured by EKF and confirmed by PHE to enable safe sample handling of clinical samples, can help to increase COVID-19 testing capacity.

Due to PrimeStore MTM’s advantages over generic VTM and UTM (viral and universal transport media) products, EKF has recently won a number of significant tenders with commercial partners involved in healthcare, education and industry to supply safe sample collection kits for COVID-19 testing programmes.

Healthcare, education and industry using PrimeStore MTM to supply safe sample collection kits for COVID-19 testing programmes

Amongst these commercial partners, EKF is now working with the University of Leicester for its student COVID-19 screening programme, and international molecular diagnostics group, Yourgene Health, to supply kits to

etc"

Arden Partners in their morning note say Buy and have retain their 7.6p per share valuation :

"We are not making any changes to our forecasts. For FY2020E, we forecast FFBs processed of 154,785MT, CPO sold of 33,883MT and an average CPO price for the year of €575/MT. We forecast FY2020E revenue of €21.9m, EBITDA of €0.8m, a post tax loss of -€1.99m and EPS of -0.5 Euro cents.

On the basis of our sum of parts valuation we value the company at 7.6p per share, equivalent a market capitalisation of £32.2m. This compares with the current share price of 2.45p and a market cap of £10.4m. We maintan our Buy recommendation."

https://research.arden-partners.com/portal/portal.html#/home

Cenkos say Buy today and see current share price levels as a buying opportunity. Here's their intro and conclusion:

"Good visibility into H2E

Given that Pelatro has visibility of over $5m of revenue for FY20E, we are leaving our forecasts unchanged following the interim results. The pipeline is strong and we are cognisant that the mix of business signed in H2E will have a proportionate impact on reported performance this year. Pelatro is trading at the lower end of its 12-month price range which creates a buying opportunity."

"Forecasts unchanged.

A new contract has been signed with an existing customer worth $1.5m over 5 years. Our forecasts are unchanged as we see this building better visibility into H2E. Pelatro's revenue performance is historically weighted to H2 and we see this proportion becoming more pronounced in FY20E at 69% (vs59% in FY19A). Pelatro's visible revenue of $5m for FY20E amounts to 68% of our revenue forecast and is stated before the positive impact from this new contract.

Strong pipeline.

The total pipeline of opportunities stands at $15m over the next 12-months, of which $8m is identified to fall into FY20E. $4m of the FY20E pipeline is with existing customers with an identified need, subject to sign-off, and is therefore of high probability of conversion. The delivery profile of newly won business will determine reported revenues but the direction of travel for the business is firmly upwards. On FY20E EV/sales of only 2.3x we are Buyers."

Positive review from Techmarketview, reflecting the benefits from COVID-19:

Https://www.techmarketview.com/ukhotviews/archive/2020/09/29/imimobile-emphasises-reasons-to-be-cheerful

"Tuesday 29 September 2020

IMImobile emphasises reasons to be cheerful

Cloud communications provider, IMImobile, has released a trading update ahead of today’s AGM, highlighting encouraging momentum across the group. The announcement, covering the six months to 30 September 2020, revealed that, helped by the addition of recent acquisitions, cloud communications products were expected to deliver an increase in gross profit of at least 20%

IMImobile also cited continued momentum across its core sectors whilst those areas most badly impacted by the pandemic (healthcare and SMEs) had shown a "significant recovery" in the current quarter. The group has made good progress in North America during the last three months, where it has successfully secured a number of new customers across a variety of sectors, including financial services, mobile and retail.

On the downside, IMImobile indicated that its operator VAS (Value Added Services) and mobile payments business, were continuing to “experience headwinds” as the global economy slows in face of COVID-19. These operations account for around 10% of IMI’s gross profit.

The latest update follows a strong FY20 for IMImobile, with the group benefitting from extra demand stimulated by the impact of the coronavirus (see: COVID creates demand for IMImobile). Whilst the future is far from certain in the face of the evolving economic challenges, IMI’s management has reasonable cause to remain optimistic about the group’s prospects."

MWE partner Nokia have just announced a big extension of their relationship with BT into 5G.

This includes its AirScale portfolio, which incorporates:

Https://www.nokia.com/networks/solutions/airscale-radio-access/?did=d000000003yx&gclid=EAIaIQobChMIgcm_xoaO7AIVRubtCh0OmgH-EAAYASAAEgKIz_D_BwE#solution-elements

"Nokia AirScale Active Antennas:

Nokia AirScale Compact Active Antennas for easy deployment on crowded antenna sites as either capacity extensions or coverage fixes
Nokia AirScale massive MIMO Adaptive Antennas to improve spectral efficiency and throughput capacity, ready to support 5G and gigabit experience"

Remember MWE's partnership with Nokia for 5G antennas as a longstanding major client?

Https://www.mtiwe.com/?CategoryID=353&ArticleID=223

Here's today's news:

Https://www.investegate.co.uk/nokia-corporation/gnw/nokia-signs-5g-deal-to-become-bt--8217-s-largest-infrastructure-partner/20200929090000H9468/

"Nokia today announced that it has extended its long-term strategic relationship with BT into the 5G arena, following its selection as a 5G RAN vendor for the UK operator. As part of the deal, which will make Nokia BT’s largest equipment provider, Nokia will provide equipment and services at BT radio sites across the UK, helping to evolve BT’s radio access network to 5G and supporting its goal of maintaining the UK’s best network....

....Nokia will supply its AirScale Single RAN (S-RAN) portfolio for both indoor and outdoor coverage, including 5G RAN, AirScale base stations and Nokia AirScale radio access products."

Results are out for the much seasonally weaker H1. The MMs have gone overboard with their reaction and are stiffing any sellers - the price has already bounced somewhat.

At 1245p the m/cap is now £22.8m. This compares to £26.02m NAV (all tangible assets), and £16.1m cash. VLE might consider re-starting their buyback programme at these levels.

Shire are doing well as predicted, with profits up around 50% against last year, though not as stellar as I hoped due to extra costs to cope with demand and increased production.

Indulgence has obviously been tough. Around £1.6m has been spent so far post-acquisition, leaving Indulgence owing VLE £2.84m to be repaid including the acquisition price, and essentially it's acted as a start-up incurring initial losses of £0.6m since February.

Good to see this news:

"I am delighted to announce that the Naughty Vegan brand is launching in a "big-4" retailer imminently."

Cash is at £16.1m after the Indulgence investment.

So overall a bit of a holding pattern methinks for this H2, whilst Indulgence is brought up to speed. Shire should have a very good H2, so their year end result will imo be great, offset to an extent by Indulgence.

H1 results are out - and imo they read pretty well.

And there's a decent-sized new contract win:

"Pelatro also announces that it has expended its relationship with a large telco group, which is a customer of Pelatro, by winning a new contract from another opco within that group. This contract is expected to contribute about US$1.5m of revenue over a 5 year period and will add to our recurring revenue base."

At the current £13.7m m/cap, $0.7m H1 adjusted EBITDA is good going. And:

- PTRO are now well funded with around £1.7m net cash
- recurring income is growing nicely and is now 67% of revenues
- good revenue visibility of $5m for full year
- near-term pipeline of $15m, of which $4m is from existing customers, so is highly likely to be won

Plus good confidence for the year end:

"As with last year, we anticipate significant weighting of revenue towards our second half. We have had a good start to the second half and we have a strong pipeline from which we expect to be able to deliver revenue in line with expectations on the basis of license sales."

Good to see confirmation of the new acquisitions being unconditional to be completed on October 31st.

This sentence sounds promising for CNIC:

"The Company is pleased to announce that the Acquisition Conditions have been satisfied or waived and substituted with adequate or better completion deliverables"

The H1 results look surprisingly good to me.....$1.9m EBITDA in H1 - and a $0.46m profit before tax :o))

Plus higher extraction rates being continued into H2, with CPO prices much higher than in H1.

The cashew preparations are now going well and will be producing in March-June next year, so not long to go. Plus DKL will be able to take advantage of the high production season from February as it can store its purchases for later production.

The balance sheet could do with some improvement, but current CPO prices and sales should help nicely.

At a mere £10m m/cap things are looking pretty optimistic at present?

Very encouraging. Lots of confidence, new contract wins, global expansion (especially the USA), COVID-affected sectors recovering well.....can't ask for more at this stage:

"Since the trading update of 9 July 2020, trading momentum across the Group has strengthened further. For the six months to 30 September 2020 the Group's cloud communications product set, which represents almost 90% of the Group's gross profit, is expected to deliver year on year gross profit growth of at least 20%. This includes a contribution from the acquisitions of 3Cinteractive and Rostrvm Solutions as well as organic growth.

Alongside continued momentum across our core sectors, volumes and activity levels in the sectors most adversely affected by the Coronavirus pandemic, notably healthcare, SMB and retail have shown significant recovery in the current quarter.

Strong progress has been made in the current quarter in North America. Multiple new customers have been won across a range of sectors including banking, financial services, insurance, mobile operators and retail, further validating our strategy in the region and technological capabilities. This is in addition to the successful launch of new strategic deployments for large US retailers which help underpin growth expectations for the second half of FY21.

The Group's operator VAS (Value Added Services) and mobile payments business, representing approximately 10% of Group gross profit has, as expected, continued to experience headwinds.

Outlook

The new contracts, which were won through competitive procurement processes, as well as a growing pipeline of opportunities in North America give the Board confidence of IMImobile's ability to compete and succeed in the largest addressable market for the Group's product set.

The Group continues to see substantial opportunities for growth in all markets in which it operates. It expects disruption caused by the pandemic to accelerate demand from large enterprises for its leading software and services as they transform their customer engagement strategies.

The Board are pleased with the Group's performance in the financial year to date and remain confident that the results for the full year will be in line with market expectations."

There were a couple of interesting snippets in the latest Cenkos note...

- the sales potential for Kelo-Cote is reckoned to be over £50m, compared to current annualised sales of around £29m
- the impact of COVID on VLG in H1 was actually neutral, with the new hand sanitiser sales offsetting reduced revenues from elsewhere and increased staff safety costs. So the H1 results would actually have been achieved anyway in a "normal" period.

So this H2 and next year should see the benefit from both the recovery in trading in the core business PLUS continuing hand sanitiser sales.

Sudden move up to 207p after a 235,000 share buy at 203p, which seems to have cleared the decks. At last!

There should be a lot of upside from here imho.

New highs - good to see 60p being paid by buyers this morning.

Looks like a 50,000 buy at 50.5p has caused a nice uptick.

Arden Partners this morning say Buy with a 24p target price, and conclude:

"Investment thesis and valuation

Currently, the Group has demonstrated its ability to sign new challenge study contracts and drive operating leverage from raising utilisation of the clinic. Ongoing activity in the market suggests there is potential to get the clinic booked up on a longer term basis which should support future forecast upgrades.

At 14.4x P/Eand 8.5x EV/EBITDA(2021), we do not see the current valuation as particularly demanding considering the current industry dynamics and the quality of assets within Open Orphan. Buy"

Hello....bid price now up to 200p, and buying is at the full 201p offer.

Looking interesting....

Zeus Capital have raised their target price to 57p in a new note, and they state interestingly:

"“Two-thirds of new projects are now for EVs.“

Progressive Equity Research have issued a note on companies with reliable, recurring revenues, including SUR (and RNWH and IMO, which I also hold). The analysis on SUR includes:

"MAIN REVENUE SOURCES

•Compliance(recurring revenue)62%
•Energy Services(recurring revenue)38%"

"DRIVERS OF RESILIENCE

•Revenues in both divisions comprise long term contracts, typically of 3-5 years
•Compliance contracts are a legal requirement
•Tackling fuel poverty a political commitment
•Smart meter roll-out is gathering pace
•Financially secure, government-backed clients"